Touchstone
Last syncNov 1, 2026, 6:55 PM ET

MDXG

Mimedx Group, Inc. Health Care Surgical & Medical Instruments & Apparatus Russell 3000
$3.88Close $574.6MMarket cap $3.09 – $7.9652-week range Jan 27, 2027Next report · estimated

Highlights

Cautions

  • Not in an uptrend 1 of 8 trend conditions
  • Lagging the market RS 18 · weaker than 82% of stocks over 12 months
  • Far from its high 51% below its 52-week high
  • Earnings shrinking EPS −153% year on year

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Oct 28, 2026
Off 12-month high 51%
1wk down 0.8% price change
1mo down 16.7% price change
12-month return down 48% market up 11% · its own down 57%
F-score 7 / 9 Strong
Altman Z 6.41 Low risk
P/E 11.8× price / earnings
PEG 0.84 P/E / EPS growth
P/B 2.2× price / book
Earnings yield up 15.0% EBIT / enterprise value
Cheaper than 86% of the market · markedly cheap
Revenue growth up 20% year on year
EPS growth down 153% latest quarter · +103 pts
Sales growth down 45% latest quarter · -11 pts
ROE up 22% return on equity
Free cash margin up 18% $74.0M FCF
D/E 0.06 long-term debt / equity
Net debt / EBITDA -1.9× net cash
Interest cover —EBIT / interest
Piotroski tests
  • issued more shares
  • gross margin narrowed
  • profitable on its assets
  • generating cash from operations
  • profitability improving
  • profits backed by cash
  • reduced long-term debt
  • short-term liquidity improved
  • assets working harder

Repair signals

  • Long-term debt down 8% ($0.0B → $0.0B)

Trade setup

ATR% 5.4% $0.21 a day · 2×ATR $3.46
RS 18 / 99 vs the universe
Trend 1 / 8 trend template
Relative volume 1.7× vs 50-day average
Up/down volume 0.96 50 sessions
Implied move — no scheduled report
Trend template · 1 of 8
  • 50-day average above the 150 and 200-day: passes

Screen verdict

Did not qualify for any screen.

Warning signs

none flagged
  • No restatement or impairment
  • Equity positive
  • Interest covered
  • No material dilution
  • Profits tracking cash
  • Margins and revenue not shrinking
Last reported Oct 28, 2026
Last shock Oct 21, 2026-12% in one session2.2× volumeno filing matched+4% since

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $418.6M +20% on FY2024
$0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $248.2M FY2021 · $242.0M FY2022 · $267.8M FY2023 · $321.5M FY2024 · $348.9M FY2025 · $418.6M
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $48.6M +15% on FY2024
-$50M $0 $100M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · -$49.3M FY2021 · -$10.3M FY2022 · -$30.2M FY2023 · $58.2M FY2024 · $42.4M FY2025 · $48.6M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $74.0M +12% on FY2024
-$50M $0 $100M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · -$30.3M FY2021 · -$5.2M FY2022 · -$19.4M FY2023 · $24.8M FY2024 · $66.2M FY2025 · $74.0M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 83%
  • Net 12%
  • Free cash 18%
-20% 0% 100% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 84% · Net -20% · Free cash -12% FY2021 · Gross 84% · Net -4% · Free cash -2% FY2022 · Gross 82% · Net -11% · Free cash -7% FY2023 · Gross 83% · Net 18% · Free cash 8% FY2024 · Gross 83% · Net 12% · Free cash 19% FY2025 · Gross 83% · Net 12% · Free cash 18%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $149.7M net cash
  • Cash
  • Long-term debt
$0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $95.8M · Long-term debt $47.7M FY2021 · Cash $87.1M · Long-term debt $48.1M FY2022 · Cash $66.0M · Long-term debt $48.6M FY2023 · Cash $82.0M · Long-term debt $48.1M FY2024 · Cash $104.4M · Long-term debt $17.8M FY2025 · Cash $166.1M · Long-term debt $16.5M
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 148.09m +33.5% since FY2020
148.09m 110.93m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 110.93m FY2021 · 111.93m FY2022 · 113.71m FY2023 · 146.23m FY2024 · 146.93m FY2025 · 148.09m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $248.2M $242.0M $267.8M $321.5M $348.9M $418.6M
Gross margin 84% 84% 82% 83% 83% 83%
Operating income -$45.4M -$7.1M -$14.7M $37.1M $58.9M $63.9M
Net income -$49.3M -$10.3M -$30.2M $58.2M $42.4M $48.6M
Net margin -20% -4% -11% 18% 12% 12%
Earnings per share -$0.46 -$0.09 -$0.27 $0.40 $0.28 $0.32
Free cash flow -$30.3M -$5.2M -$19.4M $24.8M $66.2M $74.0M
Free cash margin -12% -2% -7% 8% 19% 18%
Cash $95.8M $87.1M $66.0M $82.0M $104.4M $166.1M
Long-term debt $47.7M $48.1M $48.6M $48.1M $17.8M $16.5M
Shareholders' equity -$150,000 $82,000 -$18.0M $142.7M $193.1M $256.5M
Shares outstanding 110.93m 111.93m 113.71m 146.23m 146.93m 148.09m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Oct 28, 2026 Quarterly ↗ Sep 30, 2026 28d
Jul 29, 2026 Quarterly ↗ Jun 30, 2026 29d
Apr 29, 2026 Quarterly ↗ Mar 31, 2026 29d
Feb 25, 2026 Annual ↗ Dec 31, 2025 56d
Oct 29, 2025 Quarterly ↗ Sep 30, 2025 29d
Jul 30, 2025 Quarterly ↗ Jun 30, 2025 30d
Apr 30, 2025 Quarterly ↗ Mar 31, 2025 30d
Feb 26, 2025 Annual ↗ Dec 31, 2024 57d
Oct 30, 2024 Quarterly ↗ Sep 30, 2024 30d
Jul 31, 2024 Quarterly ↗ Jun 30, 2024 31d
Apr 30, 2024 Quarterly ↗ Mar 31, 2024 30d
Feb 28, 2024 Annual ↗ Dec 31, 2023 59d

Current reports

FiledDisclosed
Oct 28, 2026 Results · Regulation FD ↗
Oct 16, 2026 Other events ↗
Jul 29, 2026 Results · Regulation FD ↗
Jul 29, 2026 Material agreement · Regulation FD ↗
Jun 16, 2026 Charter or bylaws · Shareholder vote ↗
Apr 29, 2026 Results · Regulation FD ↗
Apr 16, 2026 Director or officer change · Regulation FD ↗
Feb 25, 2026 Results · Regulation FD ↗
Jan 12, 2026 Regulation FD ↗
Oct 29, 2025 Results · Regulation FD ↗
Sep 3, 2025 Regulation FD ↗
Jul 30, 2025 Results · Regulation FD ↗